German Fund For Infected Blood Victims

2 April 1995

The German government, the drug industry and transfusion centers have set up a fund of around $175 million to assist the 1,300 or so Germans infected with HIV from contaminated blood products.

People who were given contaminated blood products before 1988 are to get monthly payments ranging from $1,050 to $2,100, according to Health Minister Horst Seehofer. Around 600 hemophiliacs have already died from AIDS contracted from these blood products, and employees of one company are on trial charged with knowingly selling infected plasma products. Mr Seehofer has meanwhile admitted that officials in Bonn swept suspicions of the affair under the carpet.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight